Hepatitis B Human Immunoglobulin Market

Hepatitis B Human Immunoglobulin Market contains market size and forecasts of Hepatitis B Human Immunoglobulin in global, including the following market information:

Global Hepatitis B Human Immunoglobulin Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Hepatitis B Human Immunoglobulin Market Sales, 2017-2022, 2023-2028, (Litre)

Global top five Hepatitis B Human Immunoglobulin companies in 2021 (%)

The global Hepatitis B Human Immunoglobulin market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

100IU Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Hepatitis B Human Immunoglobulin include Biotest, ADMA Biologics, Sanquin Blood, Bio Products Laboratory, Baxter, CSL, Bayer, Grifols and Octapharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Hepatitis B Human Immunoglobulin manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Hepatitis B Human Immunoglobulin Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Litre)

Global Hepatitis B Human Immunoglobulin Market Segment Percentages, by Type, 2021 (%)

100IU

200IU

400IU

Global Hepatitis B Human Immunoglobulin Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Litre)

Global Hepatitis B Human Immunoglobulin Market Segment Percentages, by Application, 2021 (%)

Measles Prevention

Prevention of Hepatitis B Virus Infection

Hepatitis A Virus Infection

Other

Global Hepatitis B Human Immunoglobulin Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Litre)

Global Hepatitis B Human Immunoglobulin Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Hepatitis B Human Immunoglobulin revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Hepatitis B Human Immunoglobulin revenues share in global market, 2021 (%)

Key companies Hepatitis B Human Immunoglobulin sales in global market, 2017-2022 (Estimated), (Litre)

Key companies Hepatitis B Human Immunoglobulin sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Biotest

ADMA Biologics

Sanquin Blood

Bio Products Laboratory

Baxter

CSL

Bayer

Grifols

Octapharma

Hualan Biological

China Biologic

Tiantan Biologic

Shuanglin Bio-pharmacy

Sichuan Yuanda Shuyang

Shanghai Institute of Biological

Hualan

Shanghai RAAS Blood Products

China Grand Enterprises

Nanyue Biopharmaceutical

Boya Biopharmaceutical Group

Tonglu Biopharmaceutical

Shandong Taibang Biopharmaceutical

Guangdong Shuanglin Biopharmaceutical

Chengdu Rongsheng Pharmaceutical

Shenzhen Weiguang Biopharmaceutical

Green Cross (China) Biological Products

Sinopharm